Total planned funding: $494,638,716
Clear active filters
HTXD: Treatment: ARV Drugs
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
| Kenya | $110,900,000 |
| Nigeria | $96,557,137 |
| Ethiopia | $44,364,786 |
| South Africa | $42,986,329 |
| Uganda | $39,201,152 |
| Zambia | $27,212,000 |
| Côte d'Ivoire | $26,864,486 |
| Tanzania | $23,918,743 |
| Mozambique | $21,140,408 |
| Vietnam | $11,650,000 |
| Rwanda | $10,250,000 |
| Botswana | $9,605,000 |
| Caribbean Region | $9,364,409 |
| Zimbabwe | $7,230,000 |
| Namibia | $6,930,177 |
| Haiti | $2,862,679 |
| Guyana | $2,277,832 |
| Malawi | $650,000 |
| Eswatini | $320,000 |
| Lesotho | $176,578 |
| China | $100,000 |
| South Sudan | $77,000 |
Organizational Types
| Private Contractor | $204,131,784 |
| Unknown | $113,766,952 |
| NGO | $62,044,823 |
| University | $45,556,431 |
| FBO | $35,522,133 |
| Host Country Government Agency | $23,611,898 |
| Implementing Agency | $6,305,000 |
| Own Agency | $2,007,936 |
| Parastatal | $1,164,000 |
| Other USG Agency | $527,759 |
Program Areas
| Treatment | $494,638,716 |
Budget Codes
| HTXD: Treatment: ARV Drugs | $494,638,716 |